4559:TYO
Zeria Pharmaceutical Co Ltd
၁,၉၂၅.၀၀ JP¥
arrow_downward
-၀.၂၁%(-၄.၀၀) 1D
အောက် ၉, GMT+၉ ၁၅:၃၀:၀၀ · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
၁,၉၂၃ JP¥
High
၁,၉၄၀ JP¥
Low
၁,၉၁၉ JP¥
Mkt. cap
ဋေ ၉.၆၅ ထ
Avg. vol.
၁.၇၀ သိန်း
Volume
၇.၇၅ သောင်း
Dividend
၂.၅၅%
Quarterly dividend
၁၂ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၀.၃၁
52-wk high
၂,၄၃၄ JP¥
52-wk low
၁,၈၇၈ JP¥
EPS
၁၈၇ JP¥
Shares outstanding
၅.၀၁ ကုဋေ
No. of employees
၂ ထောင်
Open
၁,၉၂၃ JP¥
High
၁,၉၄၀ JP¥
Low
၁,၉၁၉ JP¥
Mkt. cap
ဋေ ၉.၆၅ ထ
Avg. vol.
၁.၇၀ သိန်း
Volume
၇.၇၅ သောင်း
Dividend
၂.၅၅%
Quarterly dividend
၁၂ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၀.၃၁
52-wk high
၂,၄၃၄ JP¥
52-wk low
၁,၈၇၈ JP¥
EPS
၁၈၇ JP¥
Shares outstanding
၅.၀၁ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Stock Titan
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
Simply Wall Street
·
ပြီးခဲ့သည့် ၈ မိနစ်
What Bilibili Bears Spotted Before The Slide
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၁ နာရီ
Lululemon (NASDAQ: LULU) Faces Brand Reckoning As Sales Slump And Hedge Funds Retreat
Barchart.com
·
ပြီးခဲ့သည့် ၃ နာရီ
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd